(3S,4S)-3-(5,6-Dihydro-4H-Pyrrolo[3,2,1-Ij]Quinolin-1-Yl)-4-(1H-Indol-3-Yl)Pyrrolidine-2,5-Dione structure
|
Common Name | (3S,4S)-3-(5,6-Dihydro-4H-Pyrrolo[3,2,1-Ij]Quinolin-1-Yl)-4-(1H-Indol-3-Yl)Pyrrolidine-2,5-Dione | ||
---|---|---|---|---|
CAS Number | 905854-03-7 | Molecular Weight | 369.41600 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C23H19N3O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of (3S,4S)-3-(5,6-Dihydro-4H-Pyrrolo[3,2,1-Ij]Quinolin-1-Yl)-4-(1H-Indol-3-Yl)Pyrrolidine-2,5-Dione(3S,4S)-Tivantinib is a potent and highly selective inhibitor of the receptor tyrosine kinase c-MET. (3S,4S)-Tivantinib has two novel targets, GSK3α and GSK3β, which play an important role in the cellular mechanism of non-small cell lung cancer (NSCLC)[1]. |
Name | 2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3S,4S) |
---|---|
Synonym | More Synonyms |
Description | (3S,4S)-Tivantinib is a potent and highly selective inhibitor of the receptor tyrosine kinase c-MET. (3S,4S)-Tivantinib has two novel targets, GSK3α and GSK3β, which play an important role in the cellular mechanism of non-small cell lung cancer (NSCLC)[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C23H19N3O2 |
---|---|
Molecular Weight | 369.41600 |
Exact Mass | 369.14800 |
PSA | 66.89000 |
LogP | 3.92140 |
Storage condition | 2-8°C |
Precursor 0 | |
---|---|
DownStream 1 | |
(+-)-trans-2-Propylamino-cyclohexanol-(1) |
(+)-3(S),4(S)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4(1H-indol-3-yl)pyrrolidine-2,5-dione |
2-(propylamino)cyclohexanol |
(-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione |
(1R,2R)-2-(PROPYLAMINO)CYCLOHEXANOL |